TITLE:
Analysis of Sentinel Lymph Node Biopsy on Clear Cell Sarcoma Treatment
AUTHORS:
Eurico Cleto Ribeiro de Campos, Marcos Gonçalves Adriano Júnior, Marcus Rivabem Winheski, Ricardo Poroski, Diego Sanches, Robson Menezes Leal, Marcela Cavalcanti, Emanuela Benevides Poyer, Renan Martins
KEYWORDS:
Clear Cell Sarcomas, Soft Tissue Sarcoma, Sentinel Biopsy
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.11 No.12,
December
15,
2020
ABSTRACT: Clear Cell Sarcoma (CCS)
is a rare soft tissue sarcoma that corresponds to a less than 1% of all sarcomas and is a high degree neoplasm
with propensity to disseminate to regional lymph nodes. Regional
lymphadenectomies have a controversial impact on sarcomas treatment and survival, even though
those patients have higher local recurrence and lower survival. So, sentinel
lymph node biopsy must be one option for better regional staging to STS with
higher propensity to lymph node commitment. The authors demonstrate two cases of
CCS submitted to surgery through compartmental resection associated with the sentinel lymph node
biopsy. A literature review about soft tissue sarcoma and lymph node sentinel
biopsy is shown as an initial experience of two cases.